Pittillo R F, Hunt D E
Appl Microbiol. 1967 May;15(3):531-2. doi: 10.1128/am.15.3.531-532.1967.
Methyl-5(or 4)-(3,3-dimethyl-1-triazeno)-imidazole-4(or 5)-carboxylate was shown to have in vitro antimicrobial activity against gram-positive and gram-negative bacteria, yeasts, filamentous fungi, and algae. Preliminary studies with mice, experimentally infected with Staphylococcus aureus, have shown that this new antimicrobial agent has in vivo chemotherapeutic activity comparable to that observed with penicillin.
5(或4)-甲基-(3,3-二甲基-1-三氮烯)-咪唑-4(或5)-羧酸甲酯已被证明对革兰氏阳性菌和革兰氏阴性菌、酵母、丝状真菌及藻类具有体外抗菌活性。对实验感染金黄色葡萄球菌的小鼠进行的初步研究表明,这种新型抗菌剂的体内化疗活性与青霉素相当。